首页> 外文期刊>Drug delivery. >Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
【24h】

Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.

机译:载有阿昔洛韦的藻酸盐粘膜粘附微球的胃滞留药物递送系统:制剂和评估。

获取原文
获取原文并翻译 | 示例
       

摘要

In the present study, mucoadhesive alginate microspheres of acyclovir were prepared to prolong the gastric residence time using a simple emulsification phase separation technique. The particle size of drug-loaded formulations was measured by SEM and the particle size distribution was determined using an optical microscope and mastersizer. The release profile of acyclovir from microspheres was examined in simulated gastric fluid (SGF pH 1.2). The particles were found to be discreet and spherical with the maximum particles of an average size (70.60 +/- 2.44 microm). The results indicated that the mean particle size of the microspheres increased with an increase in the concentration of polymer and decreased with increase in stirring speed. The entrapment efficiency was found to be in the range of 51.42-80.46%. The concentration of the calcium chloride (% w/v) of 10% and drug-polymer ratio of 1:4 resulted in an increase in the entrapment efficiency and the extent of drug release. The optimized alginate microspheres were found to possess good mucoadhesion (66.42 +/- 1.01%). The best fit model with the highest regression coefficient values (R(2)) was predicted by Peppas model (0.9813). In Gamma scintigraphy analysis, the section of GIT was critically analyzed and much differentiation was present at each time point after oral administration, which revealed that the optimized formulation demonstrated gastroretention in vivo for more than 4 h, which revealed that optimized formulation could be a good choice for gastroretentive systems.
机译:在本研究中,使用简单的乳化相分离技术制备了阿昔洛韦的粘膜粘附藻酸盐微球,以延长胃的停留时间。通过SEM测量装载药物的制剂的粒径,并使用光学显微镜和母粒测定仪测定粒径分布。在模拟胃液(SGF pH 1.2)中检查了阿昔洛韦从微球的释放情况。发现该颗粒是离散的和球形的,具有平均尺寸(70.60 +/- 2.44微米)的最大颗粒。结果表明,微球的平均粒径随着聚合物浓度的增加而增加,而随着搅拌速度的增加而减小。发现包封率在51.42-80.46%的范围内。氯化钙的浓度(%w / v)为10%,药物与聚合物的比例为1:4,导致包封效率和药物释放程度的增加。发现优化的藻酸盐微球具有良好的粘膜粘附性(66.42 +/- 1.01%)。 Peppas模型(0.9813)预测了具有最高回归系数值(R(2))的最佳拟合模型。在伽玛闪烁显像分析中,对GIT的切片进行了严格分析,并且在口服后的每个时间点都存在很大的差异,这表明优化的制剂在体内的胃滞留时间超过4小时,这表明优化的制剂可能是一种很好的药物。胃滞留系统的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号